Michelle Brown

STORED RED BLOOD CELLS SELECTIVELY ACTIVATE HUMAN NEUTROPHILS TO RELEASE IL-8 AND SECRETORY PLA2

Garret Zallen, Ernest E. Moore, David J. Ciesla et al. · Shock · 2000 · 162 citations

Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody-drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors

Sylvie Rottey, Jeffrey Clarke, Kyaw Aung et al. · EUR Research Repository (Erasmus University Rotterdam) · 2022 · 50 citations · Full text

HGS-ETR1, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: Results of a phase 1 and PK study

Laura Q.M. Chow, S. Gail Eckhardt, Daniel L. Gustafson et al. · Journal of Clinical Oncology · 2006 · 34 citations

Immunology, Pathology, Cell Death +20

Phase 1/2 study of mRNA-4359 administered alone and in combination with immune checkpoint blockade in adult participants with advanced solid tumors.

John D. Powderly, Ryan J. Sullivan, Martin Gutierrez et al. · Journal of Clinical Oncology · 2023 · 18 citations

Pd-l1 Tps, Immunology, Immune Regulation +20

Abstract B057: BMS-986148, an anti-mesothelin antibody-drug conjugate (ADC), alone or in combination with nivolumab demonstrates clinical activity in patients with select advanced solid tumors

Jeffrey Clarke, Siu-Chung Chu, Lillian L. Siu et al. · Molecular Cancer Therapeutics · 2019 · 17 citations

Immunoediting, Immunology, Immunotherapeutics +18